|
FY2025
12 months to Dec 31, 2025
|
FY2024
12 months to Dec 31, 2024
|
FY2023
12 months to Dec 31, 2023
|
|
|---|---|---|---|
| Revenue | |||
| Cost of revenue | |||
| Gross profit | |||
| Operating expenses: | |||
| Sales and marketing | |||
| Research and development | |||
| General and administrative | |||
| Total operating expenses: | |||
| Loss from operations | |||
| Other income (expense): | |||
| Interest expense | |||
| Changes in fair value of warrants | |||
| Changes in fair value of debt | |||
| Changes in fair value of Revenue Interest Financing and PIPE Conversion Option | |||
| Change in fair value of earn-out liabilities | |||
| Termination of convertible note side letters | |||
| Loss on extinguishment of debt | |||
| Other income (expense), net | |||
| Total other income: | |||
| Loss before income taxes | |||
| Provision for income taxes | |||
| Net loss | |||
| Cumulative undeclared preferred dividends | |||
| Net loss attributable to common shareholders | |||
| Net loss per share - Basic | |||
| Net loss per share - Diluted | |||
| Weighted-average shares outstanding - Basic | |||
| Weighted-average shares outstanding - Diluted |
Loading...
